Evaluation of Changes in Pancreatic Fat Content Using Advanced MR Sequences in Diabetics on Dapagliflozin Therapy
NCT05797935
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Lipomatosis
Interventions
DRUG:
Dapagliflozin 10mg Tab
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh